Less Glycemic Variability, Better Patient Reported Outcomes with Lantus® and Apidra® Regimen vs. Premix Analog Insulin

- Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions -

Jun 26, 2010, 10:05 ET from sanofi-aventis

$countyNameToPathMap.put("sp